# Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults

> **NCT01737892** · PHASE1,PHASE2 · TERMINATED · sponsor: **Amphastar Pharmaceuticals, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation
- **DRUG:** Arm C-Epinephrine Inhalation Aerosol CFC

## Key facts

- **NCT ID:** NCT01737892
- **Lead sponsor:** Amphastar Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** unable to validate analytical method
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737892, "Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01737892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*